Abstract Treatment of patients with lung cancer during the current COVID-19 pandemic is
challenging. Lung cancer is a heterogenous disease with a wide variety of therapeutic …

Abstract Purpose of Review Since the past year, the fast spread of coronavirus disease 2019
(COVID-19) has represented a global health threat, especially for cancer patients, that has …

To the Editor: Management of patients with lung cancer in the era of coronavirus disease
2019 (COVID-19) has become a global concern. We read with great interest the article …

Cancer patients are highly vulnerable to SARS-CoV-2 infections due to frequent contacts
with the healthcare system, immunocompromised state from cancer or its therapies …

Cancer is considered to be an independent risk factor for severe illness and higher mortality
in patients with coronavirus disease 2019 (COVID-19). These adverse outcomes have been …

SARS-CoV-2 infection does undoubtedly represent a challenge for care of patients with lung
cancer. Since symptoms of infection may overlap with underlying condition, diagnosis must …

Background/Aim: The Covid-19 epidemic has severely strained health care systems across
the globe. The impacts are multiple especially for patients cared for cancer. The Covid-19 …

The global coronavirus disease 2019 pandemic continues to escalate at a rapid pace
inundating medical facilities and creating substantial challenges globally. The risk of severe …

Lung cancer, considered one of the most common causes of cancer deaths worldwide, is a
complex disease with its own challenges. The coronavirus disease 2019 (COVID-19) …

Background Identifying lung cancer patients at an increased risk of getting SARS-CoV-2-
related complications will facilitate tailored therapy to maximize the benefit of anti-cancer …